Looking at the filing, I can see this is a Form 10-Q for Inspire Medical Systems, Inc. for the quarterly period ended September 30, 2026. The filing content is cut off mid-balance sheet, but there is sufficient substantive financial disclosure content to proceed.

Inspire Medical Systems, Inc. filed its quarterly report on Form 10-Q with the SEC on November 2, 2026, covering the fiscal quarter ended September 30, 2026.

Key Highlights

  • Total assets: The company reported total assets of $953,033 thousand as of September 30, 2026, compared to $907,317 thousand as of December 31, 2025.
  • Cash and cash equivalents: Cash and cash equivalents were $190,803 thousand at September 30, 2026, up from $104,813 thousand at December 31, 2025.
  • Short-term investments: Short-term investments stood at $137,168 thousand, down from $203,455 thousand at year-end 2025.
  • Inventories: Net inventories increased to $178,960 thousand from $145,293 thousand at December 31, 2025, according to the filing.
  • Shares outstanding: As of October 28, 2026, the registrant had 28,966,119 shares of common stock, $0.001 par value per share, outstanding.
  • Deferred tax assets: Deferred tax assets were reported at $74,196 thousand, compared to $88,667 thousand at December 31, 2025.

Inspire Medical Systems Reports Q3 2026 Financial Position

Inspire Medical Systems, Inc. (NYSE:INSP), a Delaware-incorporated medical device company headquartered in Golden Valley, Minnesota, filed its Form 10-Q for the quarterly period ended September 30, 2026. The filing was submitted as a large accelerated filer and covers consolidated balance sheet data as of September 30, 2026, compared against December 31, 2025 figures.

According to the filing, total current assets rose to $627,625 thousand at September 30, 2026, from $583,652 thousand at year-end 2025. The increase in cash and cash equivalents, from $104,813 thousand to $190,803 thousand, was partially offset by a decline in short-term investments, which fell from $203,455 thousand to $137,168 thousand. Accounts receivable, net of allowance for credit losses of $787 thousand, stood at $104,706 thousand, compared to $119,692 thousand at December 31, 2025, when the allowance was $1,080 thousand.

Long-term investments increased to $125,125 thousand from $96,330 thousand at December 31, 2025, the filing disclosed. Property and equipment, net, declined to $85,635 thousand from $97,872 thousand. Operating lease right-of-use assets were reported at $22,125 thousand, and other non-current assets totaled $18,327 thousand. The filing notes that it contains forward-looking statements subject to the company's cautionary language as described in Part I, Item 1A of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and other filings.

What Was Disclosed

Inspire Medical Systems filed a quarterly report covering its financial position as of September 30, 2026, showing total assets of $953,033 thousand, higher cash balances, increased inventories, and 28,966,119 common shares outstanding as of October 28, 2026.